
TARO
Marshall Wace’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-7,500
| Closed | -$318K | – | 2878 |
|
2024
Q1 | $318K | Buy |
+7,500
| New | +$318K | ﹤0.01% | 1835 |
|
2023
Q1 | – | Sell |
-8,348
| Closed | -$242K | – | 2848 |
|
2022
Q4 | $242K | Sell |
8,348
-835
| -9% | -$24.2K | ﹤0.01% | 2054 |
|
2022
Q3 | $275K | Sell |
9,183
-1,178
| -11% | -$35.3K | ﹤0.01% | 2259 |
|
2022
Q2 | $374K | Buy |
+10,361
| New | +$374K | ﹤0.01% | 2260 |
|
2020
Q2 | – | Sell |
-9,224
| Closed | -$565K | – | 2001 |
|
2020
Q1 | $565K | Buy |
+9,224
| New | +$565K | 0.01% | 945 |
|
2019
Q4 | – | Sell |
-39,432
| Closed | -$2.98M | – | 2094 |
|
2019
Q3 | $2.98M | Buy |
39,432
+31,418
| +392% | +$2.37M | 0.02% | 616 |
|
2019
Q2 | $685K | Buy |
+8,014
| New | +$685K | 0.01% | 987 |
|
2018
Q4 | – | Sell |
-7,007
| Closed | -$689K | – | 1861 |
|
2018
Q3 | $689K | Buy |
+7,007
| New | +$689K | 0.01% | 869 |
|
2016
Q2 | – | Sell |
-5,787
| Closed | -$829K | – | 1199 |
|
2016
Q1 | $829K | Sell |
5,787
-25,992
| -82% | -$3.72M | 0.01% | 756 |
|
2015
Q4 | $4.91M | Buy |
31,779
+2,322
| +8% | +$359K | 0.05% | 387 |
|
2015
Q3 | $4.21M | Sell |
29,457
-16,926
| -36% | -$2.42M | 0.05% | 323 |
|
2015
Q2 | $6.67M | Buy |
46,383
+9,354
| +25% | +$1.34M | 0.09% | 251 |
|
2015
Q1 | $5.22M | Sell |
37,029
-59,988
| -62% | -$8.46M | 0.07% | 308 |
|
2014
Q4 | $14.4M | Buy |
97,017
+63,889
| +193% | +$9.47M | 0.19% | 146 |
|
2014
Q3 | $5.1M | Buy |
33,128
+22,012
| +198% | +$3.39M | 0.07% | 286 |
|
2014
Q2 | $1.56M | Buy |
+11,116
| New | +$1.56M | 0.02% | 435 |
|